Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Coping strategies therapy significantly improves dementia carers' mental health, quality of life

  • Behavioral flexibility impaired after exposure to oxycodone

  • New insights link Fragile X Syndrome, Autism Spectrum Disorders

  • Rapid response for inflammation control in songbirds' brains could lead to therapies in humans

  • Epidemic spreading and neurodegenerative progression

  • Tapeworm found living inside a patient's brain: Worm removed and sequenced

  • Mental disorders due to permanent stress?

  • Brain injuries in mice treated using bone marrow stem cells, antioxidants

  • Repetitive transcranial magnetic stimulation studied for stroke rehab

  • Study of Lou Gehrig's disease shifts 'origin' focus to brain's motor neurons

  •